Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours
/in Cervical Cancer, Dendritic Cells, International Publications /von 2007-06-08 / Vaccine 2007 Aug;25(32):6037-46Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil
/in Breast Cancer, Hyperthermia, International Publications /von 2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-7Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-25[Active immunotherapy of prostate cancer with a focus on dendritic cells]
/in International Publications, Prostate Cancer /von 2007-06-01 / Actas Urol Esp 2007 Jun;31(6):668-79Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells
/in International Publications, Malignant Melanoma /von 2007-06-01 / Melanoma Res. 2007 Jun;17(3):169-76
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution